You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HJKC3-0004

Showing 1 - 25 of 1,340
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers - Liver Diseases Trial in Watford (NNC0560-0004, Placebo (NNC0560-0004))

Recruiting
  • Healthy Volunteers - Liver Diseases
  • Watford, Middlesex, United Kingdom
    Novo Nordisk Investigational Site
Nov 14, 2023

Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • Detroit, Michigan
  • +1 more
May 3, 2022

Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Augusta, Georgia
  • +1 more
Jul 14, 2022

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)

Completed
  • Hidradenitis Suppurativa
  • Fountain Valley, California
  • +90 more
Nov 8, 2022

Advanced Solid Tumor, NSCLC Trial in Shanghai (XZB-0004)

Not yet recruiting
  • Advanced Solid Tumor
  • NSCLC
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Mar 5, 2023

Type 2 Diabetes Trial in Japan (Orforglipron)

Not yet recruiting
  • Type 2 Diabetes
  • Nagoya, Aichi, Japan
  • +40 more
Aug 21, 2023

Multiple Myeloma Trial in Leicester (CC-92480, Tazemetostat, BMS-986158)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +9 more
Oct 24, 2022

Hepatitis B Trial in Finland (HBVAXPRO™)

Completed
Has Results
  • Hepatitis B
  • HBVAXPRO™
  • Kokkola, Mellersta Osterbotten, Finland
  • +9 more
Jul 20, 2022

AML, MDS Trial in Tianjin (XZB-0004)

Not yet recruiting
  • AML
  • MDS
  • Tianjin, Tianjin, China
    Hematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023

Guillain-Barre Syndrome Trial in Japan (Eculizumab, Placebo)

Completed
  • Guillain-Barre Syndrome
  • Eculizumab
  • Placebo
  • Bunkyo-ku, Japan
  • +25 more
Aug 26, 2022

Relapsing Forms of Multiple Sclerosis Trial in China, Japan (Diroximel fumarate)

Recruiting
  • Relapsing Forms of Multiple Sclerosis
  • Diroximel fumarate
  • Tianjin, China
  • +23 more
Jul 22, 2022

Advanced Melanoma Trial in Worldwide (lenvatinib, pembrolizumab)

Active, not recruiting
  • Advanced Melanoma
  • Chandler, Arizona
  • +22 more
Jul 21, 2022

Intraventricular Haemorrhage Neonatal, Death; Neonatal Trial in Worldwide (Umbilical cord milking UCM, Delayed cord clamping

Completed
  • Intraventricular Haemorrhage Neonatal
  • Death; Neonatal
  • Umbilical cord milking UCM
  • Delayed cord clamping DCC
  • Birmingham, Alabama
  • +17 more
Nov 22, 2022

Pneumococcal Disease Trial in Chile, United States (V116, Placebo, PCV15)

Active, not recruiting
  • Pneumococcal Disease
  • V116
  • +3 more
  • Phoenix, Arizona
  • +19 more
Dec 21, 2022

Hereditary Angioedema (HAE) Trial in Japan (Lanadelumab)

Completed
  • Hereditary Angioedema (HAE)
  • Toyohashi-shi, Aichi-Ken, Japan
  • +11 more
Sep 23, 2021

Merkel Cell Carcinoma Trial in Worldwide (Pembrolizumab (MK-3475))

Active, not recruiting
  • Merkel Cell Carcinoma
  • Pembrolizumab (MK-3475)
  • New York, New York
  • +21 more
Nov 30, 2022

Solid Tumors, Lymphoma Trial in Worldwide (Ulevostinag, Pembrolizumab)

Completed
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +18 more
Jun 10, 2022

Pulmonary Arterial Hypertension Trial in United States (Pemziviptadil (PB1046) Injection)

Terminated
  • Pulmonary Arterial Hypertension
  • Pemziviptadil (PB1046) Injection
  • La Jolla, California
  • +15 more
Feb 4, 2022

Psoriasis Trial in Japan (BMS-986165)

Completed
  • Psoriasis
  • Nagoya, Aichi, Japan
  • +26 more
Mar 21, 2022

Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)

Active, not recruiting
  • Advanced Gastric Cancer
  • Nivolumab
  • +4 more
  • Phoenix, Arizona
  • +34 more
Aug 18, 2022

Covid19 Trial in Japan, Thailand (K-237 0.3-0.4mg/kg (once daily), Placebo 0.3-0.4mg/kg (once daily))

Active, not recruiting
  • Covid19
  • K-237 0.3-0.4mg/kg (once daily)
  • Placebo 0.3-0.4mg/kg (once daily)
  • Aichi, Japan
  • +54 more
Aug 7, 2022

Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open

Not yet recruiting
  • Systemic Sclerosis
  • Scleroderma
  • Anifrolumab (blinded)
  • +2 more
  • Birmingham, Alabama
  • +130 more
Jun 22, 2023

Papillomavirus Infections, Coronavirus Disease (COVID-19) Trial in United States (9vHPV Vaccine, mRNA-1273 Vaccine)

Recruiting
  • Papillomavirus Infections
  • Coronavirus Disease (COVID-19)
  • 9vHPV Vaccine
  • mRNA-1273 Vaccine
  • Phoenix, Arizona
  • +37 more
Jan 18, 2023

Type 2 Diabetes Trial in Japan (Tirzepatide, Oral antihyperglycemic medication (OAM))

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Chiba-shi, Chiba, Japan
  • +33 more
Jan 21, 2022

Various Advanced Cancer Trial in Worldwide (Nivolumab, Ipilimumab)

Completed
Has Results
  • Various Advanced Cancer
  • Nivolumab
  • Ipilimumab
  • Los Angeles, California
  • +53 more
Jul 14, 2022